The FDA announced on September 26, 2019, that Alkermes, Inc. is recalling Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial kits due to a labeling hazard. The agency said the recall involves 16,231 kits distributed nationwide in the USA and Canada.
How to tell if you have it
- Brand: Alkermes
- Product: Vivitrol (naltrexone for extended-release injectable suspension) 380 mg/vial
- Kit NDC: 65757-300-01
- Lot codes: 2019-1002T, 2019-1003T
- Expiration date: 05/2021
- Quantity: 16,231 kits
The hazard
The drug product kit was recalled because 1-inch needles were placed in the 1 1/2-inch needle cardboard sleeve labeled as administration needles. The FDA said the product vial is not impacted by this labeling error.
Context
GovInfoNow's records show Alkermes, Inc. has 3 other recalls on record since 2012-11-06. Other recent recalls of similar products include Meitheal Cetrorelix Acetate Injection Kit Recall (2026-02-09), Lupin Liraglutide 18mg/3mL Injection Recall (2026-04-24) and American Regent Papaverine HCl Injection Recall (2026-07-24).